对比增强MRI在管理不一致空芯针活检结果中的应用
研究纳入45例患者46个超声或立体定向活检结果与影像不一致的BI-RADS 4级病灶,评估对比增强MRI对手术分流的价值;MRI阴性或良性者经随访验证,41例42个病灶的敏感度100%、特异度93.3%、阳性预测值85.7%、阴性预测值100%,31例(68.9%)避免手术。
要点
- 对比增强MRI可用于不一致良性空芯针活检结果的分流,避免不必要的手术。
- MRI阴性预测值达100%,阴性或良性结果经至少1年影像随访稳定性验证。
- 46个不一致病灶中8个最终为恶性,恶性率17.3%,符合BI-RADS 4级预期。
核心结论
- 在管理不一致良性空芯针活检结果时,对比增强MRI有助于成功将患者分流至手术,45例中31例(68.9%)避免了手术。
研究设计与样本
- 研究纳入2012年至2018年中接受对比增强MRI的45例患者46个病灶,均为超声或立体定向活检结果与影像不一致且诊断影像为BI-RADS 4级;疾病阳性定义为所有恶性肿瘤和交界性病变。
诊断标准与关键数值
- 14例患者MRI表现可疑,31例无可疑表现;在41例42个病灶且记录至少1年稳定性的组中,MRI敏感度100%、特异度93.3%、阳性预测值85.7%、阴性预测值100%,假阴性率0%,假阳性率2/30(6.7%)。
临床应用与阅片要点
- MRI阴性或良性结果在27例28个病灶经至少1年影像随访稳定性验证、4例经至少6个月验证;46个不一致病灶中8个最终恶性,恶性率17.3%,为BI-RADS 4级病灶的预期结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. Evaluating concordance between core biopsy results and imaging findings is an integral component of breast intervention. Pathologic results deemed benign discordant reflect concern that a malignancy may have been incorrectly sampled. Standard of care currently is surgical excision, although a large percentage of these lesions will be benign at final pathologic analysis. The purpose of this study was to determine whether inclusion of contrast-enhanced MRI would optimize patient care. MATERIALS AND METHODS. Forty-five patients with 46 lesions were identified who underwent contrast-enhanced MRI after receiving discordant ultrasound or stereotactic biopsy results between 2012 and mid 2018. These findings were classified BI-RADS category 4 at diagnostic imaging. Disease-positive was defined as all malignancies and borderline lesions. RESULTS. Fourteen patients had suspicious MRI findings; 31 patients did not. Negative or benign MRI findings were validated by stability at imaging follow-up of at least 1 year in 27 patients (28 lesions) and at least 6 months in four patients. Eight of the total of 46 discordant lesions were ultimately malignant, a rate of 17.3%, an expected result for BI-RADS 4 lesions. Sensitivity, specificity, positive predictive value, and negative predictive value of MRI calculated in the group of 41 patients (42 lesions) with documented stability for at least 1 year were 100%, 93.3%, 85.7%, and 100%. The false-negative rate of MRI was 0%; the false-positive rate was 2 of 30 (6.7%). CONCLUSION. In the management of discordant benign core biopsy results, contrast-enhanced MRI facilitated successful triage of patients to surgery; 31 of the original 45 patients (68.9%) avoided surgery.
引用
- Sanders LM, El-Madany M, Persing A, et al. Use of Contrast-Enhanced MRI in Management of Discordant Core Biopsy Results. AJR Am J Roentgenol. 2019. PMID: 30835519. doi:10.2214/AJR.18.20157
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。